Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Cardinal Health $2.9 billion notes offering
The investment-grade notes are due 2026, 2029, 2034 and 2054
Equinix €1.15 billion green bond offering
We advised Equinix on the euro notes offering
Omnicell $172.5 million convertible senior notes offering
The convertible senior notes are due 2029
General Mills $1.5 billion notes offering
The investment-grade notes are due 2030 and 2035
MicroStrategy $3 billion convertible notes offering
The convertible notes are due 2029
MARA Holdings $1 billion convertible notes offering
The convertible notes are due 2030
Synaptics $400 million convertible senior notes offering
The 0.75% convertible notes are due 2031
NatWest Group $750 million contingent convertible Additional Tier 1 notes
We advised NatWest Group on the SEC-registered offering
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
PG&E $500 million fixed-to-fixed reset rate junior subordinated notes offering
The 7.375% fixed-to-fixed reset rate junior subordinated notes are due 2055